Prescription-only medicines. Product information on this site is intended for healthcare professionals in Pakistan.
Home›Medicines›Urology›Tamstone®
Urology

Tamstone®

Tamsulosin HCl
0.4 mg capsulesPack of 20Rx only

Tamsulosin hydrochloride 0.4 mg modified-release capsules from the Salventis urology portfolio.

Tamstone® 0.4 mg carton
Product overview

Tamsulosin 0.4 mg

Tamstone® contains tamsulosin hydrochloride 0.4 mg as modified-release pellets, in a pack of 20 capsules. Tamsulosin is a selective α1A-adrenoceptor antagonist that relaxes prostate and bladder-neck smooth muscle.

Selective α1A antagonist

Acts on the adrenoceptors of the prostate and bladder neck.

Modified-release pellets

Each capsule contains tamsulosin HCl 0.4 mg as modified-release pellets.

Pack of 20

Twenty capsules per carton.

Prescribing essentials

Prescribing information

Composition

Each capsule contains tamsulosin hydrochloride 0.4 mg (modified-release pellets).

Dosage & administration

As directed by the physician — see the approved prescribing information.

Storage

As stated on the carton. Keep out of reach of children.

Safety & precautions

Indication, contraindications, warnings and adverse reactions are set out in the approved prescribing information, available to healthcare professionals on request.

Composition & presentation

Product information

BrandTamstone®
GenericTamsulosin HCl
Strength0.4 mg per capsule
Dosage formCapsule, modified-release pellets
Pack20 capsules
Therapeutic areaUrology
Prescription statusPrescription-only medicine
ManufacturerBiogen Life Sciences, Rawalpindi
Manufacturing licence no.000911
DRAP registration no.135438
Marketed bySalventis Pharma SMC (Pvt.) Ltd., Islamabad
Resources

Prescribing information

PI
Full prescribing information — Tamstone®Provided to healthcare professionals on request by Salventis Pharma.
Request
Explore the portfolio

Related medicines

For healthcare professionals. All Salventis products are prescription-only medicines, to be sold on the prescription of a registered medical practitioner. Information on this site summarises the approved prescribing information and supplied product literature; it is not a substitute for the full prescribing information, which is available on request from Salventis Pharma. To report a suspected adverse reaction, contact info@salventispharma.com.